News Vimab Group AB

Equities

VIMAB

SE0007439633

Delayed Nasdaq Stockholm Other stock markets 15:15:19 02/05/2024 BST			5-day change	1st Jan Change
10.55 ^SEK	+0.48%		+2.43%	+19.07%

04-02	Vimab Group AB (OM:VIMAB) has entered into a letter of intent to acquire Elb Kraft Ab for SEK 45 million.	CI
03-26	Vimab Group AB (OM:VIMAB) entered into a letter of intent to acquire Sweden Construction And Services Ab for SEK 35 million.	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Vimab Group AB (OM:VIMAB) has entered into a letter of intent to acquire Elb Kraft Ab for SEK 45 million.	04-01	CI
Vimab Group AB (OM:VIMAB) entered into a letter of intent to acquire Sweden Construction And Services Ab for SEK 35 million.	03-25	CI
Vimab Group AB Reports Earnings Results for the Full Year Ended December 31, 2023	03-12	CI
Vimab Group AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	03-12	CI
Headsent AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-10	CI
Vimab Group AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-10	CI
Vimab Group AB (OM:VIMAB) completed the acquisition of B Göransson Produktion Ab for SEK 24.2 million.	28/06/23	CI
Vimab Group AB (OM:VIMAB) signed letter of intent to acquire Solomon Oy for â‚¬2.3 million.	19/06/23	CI
Vimab Group AB (OM:VIMAB) enters into letter of intent to acquire Pjp Piping Ab for SEK 12 million.	07/05/23	CI
Vimab Group AB (OM:VIMAB) entered into letter of intent to acquire B Göransson Produktion Ab for SEK 24 million.	16/04/23	CI
Josab Water Solutions AB announced that it expects to receive SEK 42.585 million in funding from Vimab Group AB	29/03/23	CI
Vimab Group AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022	23/03/23	CI
Vimab Group AB (OM:VIMAB) signed a letter of intent to acquire 100% stake in Aoo Cnc Ab for SEK 23.3 million.	04/12/22	CI
Headsent AB will Change its Name to Vimab Group AB	11/08/22	CI
Vimab Group AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	10/08/22	CI
Vimab Holding Ab completed the acquisition of Headsent AB (OM:VIMAB) in a reverse merger	26/07/22	CI
Vimab Holding Ab entered into a conditional share transfer agreement to acquire Headsent AB (OM:VIMAB) in a reverse merger for approximately SEK 150 million.	30/05/22	CI
Headsent AB Reports Earnings Results for the First Quarter Ended March 31, 2022	28/04/22	CI
Headsent AB Reports Earnings Results for the Full Year Ended December 31, 2021	10/02/22	CI
Headsent AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2021	10/02/22	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Vimab Group AB

Equities

VIMAB

SE0007439633

Summary

Filters